— Published Date: 1/4/2025
Value Proposition: New composition of matter that combines tetracycline class compounds with destructase inhibitors to overcome resistance to tetracycline antibiotics.
Technology Description
Researchers at Washington University in St. Louis have developed an enzymatic…
— Published Date: 1/4/2025
Value Proposition: New composition of matter that combines tetracycline class compounds with destructase inhibitors to overcome resistance to tetracycline antibiotics.
Technology Description
Researchers at Washington University in St. Louis have developed an enzymatic…
— Value Proposition: Long non-coding RNA as biomarker and therapeutic target for treating diagnosed multiple myeloma patients.
Technology Description
Researchers at Washington University in St. Louis have developed a long non-coding RNA as a diagnostic marker and clinical target for multiple my…
— Value Proposition: This invention targets MXRA8 protein as a therapy for obesity and other metabolic diseases.
Technology Description
Researchers at Washington University in St. Louis have developed an MXRA8 targeted therapeutic to treat obesity and associated metabolic diseases. MXRA8 is the re…
— Technology Description
Researchers at Washington University in St. Louis have developed a novel method that uses fluorescence lifetime to simultaneously record, and measure neuromodulator change over transient and chronic time scales, promising to reveal the roles of multi-time scale neuromodulato…
| Name | # Summaries | Author |
|---|---|---|
| 15 | ||
| 13 | ||
| 15 | ||
| 26 | ||
| 14 | ||
| 14 |
Creating...
